Corrigendum—Renewal of Provisional Consent to the Distribution of Medicines

In the notice published in the New Zealand Gazette, 26 January 2017, Issue No. 8, Notice No. 2017-go297, replace the Schedule with:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Proleukin
Aldesleukin 18MIU
Powder for injection
Novartis New Zealand Limited
Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany

Note: This renewed consent is valid for two years from 29 January 2017.

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Verorab
Rabies vaccine, Wistar PM/WI 38-1503-3M 2.5IU
Powder for injection with diluent
Sanofi-aventis New Zealand Limited
Sanofi Pasteur SA, Marcy L’Etoile, France
Sanofi Pasteur SA, Val-De-Reuil Cedex, France

Note: This renewed consent is valid for six months from 27 January 2017.

Dated this 12th day of April 2017.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Corrigendum—Renewal of Provisional Consent to the Distribution of Medicines

Tags

Notice Number

Issue Number